Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1

Conditions

Multiple Myeloma 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Burkitt Lymphoma 14Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Recurrence 4Lymphoma, Mantle-Cell 4Leukemia 4Vomiting 3Neoplasms 3Nausea 3Leukemia, Myeloid, Acute 3Leukemia, Biphenotypic, Acute 3Breast Neoplasms 3Blast Crisis 3Smoldering Multiple Myeloma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Plasmacytoma 2Ovarian Neoplasms 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hodgkin Disease 2Waldenstrom Macroglobulinemia 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Squamous Cell Carcinoma of Head and Neck 1

Interventions

Melphalan 5fludarabine phosphate 3fludarabine 3Whole-Body Irradiation 3Peripheral Blood Stem Cell Transplantation 3Mycophenolic Acid 3Cyclophosphamide 3Tacrolimus 2pomalidomide 1ixazomib 1elotuzumab 1dexamethasone acetate 1dexamethasone 21-phosphate 1carmustine, poliferprosan 20 drug combination 1carfilzomib 1auricularum 1Stem Cell Transplantation 1Sirolimus 1Panobinostat 1Lenalidomide 1High-Throughput Screening Assays 1Gemcitabine 1Filgrastim 1Etoposide 1Dexamethasone 1Cytarabine 1Carmustine 1Calcium Dobesilate 1Busulfan 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, Plasma Cell × dexamethasone 21-phosphate × Clear all
NCT02547662 2023-10-30

Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients With Previously Treated Multiple Myeloma or Plasma Cell Leukemia

Mayo Clinic

Phase 2 Completed
17 enrolled 13 charts
Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell, Multiple Myeloma, Plasmacytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡